ENDRA Life Sciences (NDRA) director Harsh received 109,492 Stock Options
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Michael Harsh (director at ENDRA Life Sciences Inc., NDRA) reported that they received 109,492 Stock Options on Mar 28, 2022.
- Reporting person
- Harsh Michael
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 28, 2022 | Grant or award (A) | Stock OptionsOn 109,492 Common Stock1 | +109,492 | - | - | 109,492 direct |
Holdings before and after
- Stock Options: 0 to 109,492 direct
Footnotes from the filing
- 1. This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Harsh report in this NDRA Form 4?
Michael Harsh (director at ENDRA Life Sciences Inc., NDRA) reported that they received 109,492 Stock Options on Mar 28, 2022.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for NDRA
Earlier insider filings at NDRA
- Mar 30, 2022SEC Form 4 filed by Michelon Francois Roger
- Mar 30, 2022SEC Form 4 filed by Basenese Lou
- Jan 4, 2022SEC Form 4 filed by Tokman Alexander Y
- Jan 4, 2022SEC Form 4 filed by Digiandomenico Anthony
- Jan 4, 2022SEC Form 4 filed by Harsh Michael
Quantisnow market dataNASDAQ
NDRA
ENDRA Life Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Get push alerts for NDRA
Full NDRA profile on Quantisnow Follow NDRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time